Real-World Data Show Trastuzumab Deruxtecan Extends Survival in HER2-Low Metastatic Breast Cancer
A real-world cohort of 126 Chinese patients shows trastuzumab deruxtecan delivers a median 9.1 months of progression-free survival in HER2-low ...
Tag: progesterone receptor
MicroRNA Drop and CDK7 Signal Offer New Clues for Breast Cancer Diagnosis
A new study finds that the tumor-suppressive microRNA miR-199a-3p is significantly depleted in breast cancer tissue and that combining its ...
Hormone Receptor Levels Predict Who Benefits Most from Standard Advanced Breast Cancer Therapy
The largest real-world study of its kind shows that quantitative oestrogen and progesterone receptor levels, measured in recent tumour biopsies, ...
Ultrasound Scan Before Chemotherapy Predicts How Breast Tumors Will Shrink
Researchers in Nanjing show that pretreatment contrast-enhanced ultrasound combined with molecular markers can predict whether breast tumors will shrink concentrically ...
Metabolic Enzyme ME1 Emerges as Key to Unlocking Progestin Therapy in Endometrial Cancer
Japanese researchers found that the metabolic enzyme ME1 predicts poor outcomes in endometrioid endometrial carcinoma and that inhibiting it restores ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!